Last $0.30 USD
Change Today +0.0072 / 2.48%
Volume 149.8K
HEB On Other Exchanges
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David R. Strayer M.D.

Chief Medical Officer and Medical Director, Hemispherx Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. David R. Strayer, M.D., has been Medical Director of Hemispherx Biopharma, Inc. since 1986 and serves as its Chief Medical Officer. Dr. Strayer served as a Professor of Medicine at the Medical College of Pennsylvania and Hahnemann University, He is Board Certified in Medical Oncology and Internal Medicine with research interests in the fields of cancer and immune system disorders. Dr. Strayer has served as principal investigator in studies funded by the Leukemia ...

Read Full Background

Corporate Headquarters*

One Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-988-0080
Fax: 215-988-1739

Board Members Memberships*

There is no Board Members Memberships data available.


MD 1972
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

Total Annual Compensation$265,493

Stock Options*

All Other Compensation$25,602
Exercisable Options190,000
Total Number of Options190,000

Total Compensation*

Total Annual Cash Compensation$291,095
Total Short Term Compensation$265,493
Other Long Term Compensation$25,602
Total Calculated Compensation$291,095
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.30 USD +0.0072


Frank Mathias Chief Executive Officer and Member of Executive Board
MediGene AG
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Christopher Nishan Garabedian Chief Executive Officer, President and Director
Sarepta Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at